These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3931050)

  • 1. [Effect of the test with the drug Nakom on the dynamics of excretion of catecholamines and DOPA in children with Duchenne's progressive muscular dystrophy].
    Badalian LO; Temin PA; Grinio ZN; Amanova ZN; Sadovskaia IuE
    Pediatriia; 1985 May; (5):54-5. PubMed ID: 3931050
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of retabolyl on the dynamics of urinary catecholamine and DOPA excretion and electroneuromyographic indices in patients with Duchenne's myodystrophy].
    Badalian LO; Temin PA; Amanova ZN; Avakian GN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(11):1630-5. PubMed ID: 6441403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Value of the test with Nakom for assessing the state of the sympathoadrenal system in patients with different forms of progressive muscular dystrophy].
    Badalian LO; Amanova ZN; Temin PA
    Lab Delo; 1984; (11):649-52. PubMed ID: 6084734
    [No Abstract]   [Full Text] [Related]  

  • 4. [Diurnal rhythm of catecholamines and DOPA excretion in the urine of obese children].
    Solov'ev AN; Kartelishev AV; Severtseva VV
    Pediatriia; 1977 Sep; (9):24-8. PubMed ID: 563049
    [No Abstract]   [Full Text] [Related]  

  • 5. [Circadian rhythm of catecholamine excretion, effect of L-DOPA and Nacom in various diseases of the nervous system].
    Iadgarov IS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(12):1792-6. PubMed ID: 6229955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical results of using Nakom in diseases of the nervous system].
    Evtushenko SK; Sadekov IA; Samsonenko RA; Mogilevskaia GS; Prokhorova LM; Ostropolets SS; Osadchiĭ VG; Va'skovskaia ME
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(8):35-7. PubMed ID: 2686319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pattern of urinary catecholamines and their metabolites in Duchenne myopathy, in relation to disease evolution.
    Dalmaz Y; Peyrin L; Mamelle JC; Tuil D; Gilly R; Cier JF
    J Neural Transm; 1979; 46(1):17-34. PubMed ID: 501348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Free catecholamines and DOPA in healthy children 4-17 years of age].
    Gugutishvili TsG
    Pediatriia; 1974 Dec; (12):42-3. PubMed ID: 4444904
    [No Abstract]   [Full Text] [Related]  

  • 9. [Catecholamine concentration in the blood and excretion in the urine in different forms of progressive muscular dystrophy].
    Badalian LO; Temin PA; Dzhabarov BD; Bespalova VA; Kret LA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(3):339-42. PubMed ID: 6426220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [L-DOPA test for evaluating in vivo catecholamine biosynthesis in normal persons and persons with different diseases].
    Vasil'ev VN; Matlina ESh
    Vopr Med Khim; 1977; (3):332-8. PubMed ID: 888397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum cytoplasmic and mitochondrial aspartate aminotransferase in Duchenne's progressive muscular dystrophy.
    Janik P; Nowak I; Niebrój-Dobosz I
    Mater Med Pol; 1994; 26(3):101-4. PubMed ID: 7603078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diurnal urine excretion of catecholamines and DOPA in tumors of the sympathetic nervous system in children].
    Kharchenko AD; Kniazev IuA; Bukhny AE; Kovalev GP; Kosiakov GA
    Pediatriia; 1969 May; 48(5):51-4. PubMed ID: 4309285
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of a test with 0.1 g of L-DOPA on the dynamics of urinary excretion of catecholamines and DOPA in schizophrenic patients].
    Vasil'ev VN
    Vopr Med Khim; 1980; 26(6):782-6. PubMed ID: 6779421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duchenne's muscular dystrophy in six siblings. The case for early diagnosis and neonatal screening.
    Moosa A
    S Afr Med J; 1982 Nov; 62(21):765-7. PubMed ID: 7135141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of differences in platelet dihydroxyphenylalanine (dopa) oxidase polymorphism in health and Duchenne's muscular dystrophy.
    Pacold I; Morgan J; Cohen L
    Clin Genet; 1975; 7(5):435-41. PubMed ID: 807447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiomyopathy in children with Duchenne's progressive muscular dystrophy.
    Sanyal SK; Johnson WW
    Indian Heart J Teach Ser; 1980; (6):258-75. PubMed ID: 7309047
    [No Abstract]   [Full Text] [Related]  

  • 17. [Catecholamines and the dopamine-beta-hydroxylase activity of the blood plasma in motor pathology in children: the role of central and peripheral mechanisms].
    Brin IL; Drozdov AZ; Kovaleva IA; Filatova TS; Kogan BM
    Zh Nevrol Psikhiatr Im S S Korsakova; 1994; 94(3):7-12. PubMed ID: 7975996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [State of catecholamine and DOPA excretion in metabolic-alimentary obesity].
    Frolova IA; Beiul EA; Volkova IS; Sirota II
    Vopr Med Khim; 1974 May; 20(3):257-65. PubMed ID: 4836785
    [No Abstract]   [Full Text] [Related]  

  • 19. [Lipid peroxidation in children with Duchenne's hereditary myopathy].
    Grinio LP; Orlov ON; Prilipko LL; Kagan VE
    Biull Eksp Biol Med; 1984 Oct; 98(10):423-5. PubMed ID: 6498321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Electrocardiographic study of progressive muscular dystrophy Duchenne's type].
    De los Arcos E; Sánchez Cascos A; De Rábago P
    Rev Esp Cardiol; 1969; 22(2):193-200. PubMed ID: 5801957
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.